Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 6:38 PM
Ignite Modification Date: 2025-12-25 @ 4:09 PM
NCT ID: NCT00211757
Description: None
Frequency Threshold: 1
Time Frame: 6 weeks on treatment
Study: NCT00211757
Study Brief: Divalproex Sodium vs. Placebo in Childhood/Adolescent Autism
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Placebo Subjects in this arm will receive a placebo comparative to the study drug divalproex sodium. Placebo: Placebo comparator. 0 None 0 11 8 11 View
Divalproex Sodium Subjects will receive the study drug, divalproex sodium. Divalproex sodium: Study drug. 0 None 0 16 7 16 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Insomnia NON_SYSTEMATIC_ASSESSMENT General disorders None View
Rash SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Weight gian SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders None View
headache NON_SYSTEMATIC_ASSESSMENT General disorders None View
polyuria NON_SYSTEMATIC_ASSESSMENT General disorders None View
agitation NON_SYSTEMATIC_ASSESSMENT General disorders None View
Infection NON_SYSTEMATIC_ASSESSMENT Immune system disorders None View
Hypersomnolence SYSTEMATIC_ASSESSMENT General disorders None View